{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:35:17Z","timestamp":1772033717462,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Kosaki overgrowth syndrome (KOGS) is a rare genetic disorder linked to germline variants in the platelet-derived growth factor receptor beta gene (\n                      <jats:italic toggle=\"yes\">PDGFRB<\/jats:italic>\n                      ) that is characterized by postnatal overgrowth, hyperelastic skin, lipodystrophy, and craniofacial anomalies. This study aimed to summarize clinical and genetic data from reported KOGS cases and investigate the molecular consequences of two recurrent KOGS-associated\n                      <jats:italic toggle=\"yes\">PDGFRB<\/jats:italic>\n                      variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical and genetic information from 17 previously published KOGS cases was reviewed. Molecular studies were performed using patient-derived fibroblasts and genetically modified cells transduced with the recurrent\n                      <jats:italic toggle=\"yes\">PDGFRB<\/jats:italic>\n                      variants Trp566Arg and Pro584Arg. Downstream signaling and phosphorylation of PDGFR\u03b2 tyrosine residues were assessed by immunoblotting and immunocytochemistry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both variants induced phosphorylation of specific PDGFR\u03b2 tyrosine residues and activated downstream signaling pathways in the absence of ligand stimulation, which could contribute to the phenotypic overgrowth observed in KOGS. Immunocytochemistry revealed vesicle-like structures of phosphorylated PDGFR\u03b2 (pY740), resembling wild-type cells stimulated with growth factor, thereby supporting the constitutive activation of PDGFR\u03b2 in patient fibroblasts. Both variants showed sensitivity to the tyrosine kinase inhibitor imatinib.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Recurrent\n                      <jats:italic toggle=\"yes\">PDGFRB<\/jats:italic>\n                      variants in KOGS cause ligand-independent activation of PDGFR\u03b2, contributing to the overgrowth phenotype. Imatinib may represent a potential targeted therapeutic option.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcd.0000000000000547","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:03:10Z","timestamp":1762970590000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent platelet-derived growth factor receptor beta gene mutations in Kosaki overgrowth syndrome: a molecular and clinical overview"],"prefix":"10.1097","volume":"35","author":[{"given":"Titas","family":"Gladkauskas","sequence":"first","affiliation":[{"name":"Bergen Center for Medical Stem Cell Research"},{"name":"Department of Clinical Medicine, University of Bergen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana","family":"Cristea","sequence":"additional","affiliation":[{"name":"Bergen Center for Medical Stem Cell Research"},{"name":"Department of Clinical Medicine, University of Bergen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roya","family":"Mehrasa","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ove","family":"Bruland","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Haukeland University Hospital, Bergen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie F.","family":"Rustad","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Faivre","sequence":"additional","affiliation":[{"name":"Centre de G\u00e9n\u00e9tique et Centre de R\u00e9f\u00e9rence Anomalies du D\u00e9veloppement et Syndromes Malformatifs, FHU TRANSLAD, CHU Dijon Bourgogne"},{"name":"INSERM UMR1231 GAD, Universit\u00e9 Bourgogne Europe, FHU TRANSLAD, Dijon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyvind","family":"R\u00f8dahl","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Bergen"},{"name":"Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie","family":"Bredrup","sequence":"additional","affiliation":[{"name":"Bergen Center for Medical Stem Cell Research"},{"name":"Department of Clinical Medicine, University of Bergen"},{"name":"Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"R1-20260225","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine.","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev"},{"key":"R2-20260225","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1038\/onc.2015.383","article-title":"PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.","volume":"35","author":"Arts","year":"2016","journal-title":"Oncogene"},{"key":"R3-20260225","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1074\/jbc.273.27.17050","article-title":"Full activation of the platelet-derived growth factor \u03b2-receptor kinase involves multiple events.","volume":"273","author":"Baxter","year":"1998","journal-title":"J Biol Chem"},{"key":"R4-20260225","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41431-018-0323-z","article-title":"A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome.","volume":"27","author":"Bredrup","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"R5-20260225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/hmg\/ddab014","article-title":"Temperature-dependent autoactivation associated with clinical variability of PDGFRB Asn666 substitutions.","volume":"30","author":"Bredrup","year":"2021","journal-title":"Hum Mol Genet"},{"key":"R6-20260225","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrc1434","article-title":"Switching on kinases: oncogenic activation of BRAF and the PDGFR family.","volume":"4","author":"Dibb","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R7-20260225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cge.13752","article-title":"Kosaki overgrowth syndrome: a novel pathogenic variant in PDGFRB and expansion of the phenotype including cerebrovascular complications.","volume":"98","author":"Foster","year":"2020","journal-title":"Clin Genet"},{"key":"R8-20260225","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/cge.13192","article-title":"Phenotype expansion and development in Kosaki overgrowth syndrome.","volume":"93","author":"Gawli\u0144ski","year":"2018","journal-title":"Clin Genet"},{"key":"R9-20260225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/iovs.64.14.9","article-title":"Corneal vascularization associated with a novel PDGFRB variant.","volume":"64","author":"Gladkauskas","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-20260225","doi-asserted-by":"crossref","first-page":"a017459","DOI":"10.1101\/cshperspect.a017459","article-title":"Endocytosis of receptor tyrosine kinases.","volume":"5","author":"Goh","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"R11-20260225","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1007\/s00018-020-03753-y","article-title":"PDGF receptor mutations in human diseases.","volume":"78","author":"Gu\u00e9rit","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"R12-20260225","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1091\/mbc.e08-12-1228","article-title":"Activation of protein kinase C \u03b1 is necessary for sorting the PDGF \u03b2-receptor to Rab4a-dependent recycling.","volume":"20","author":"Hellberg","year":"2009","journal-title":"Mol Biol Cell"},{"key":"R13-20260225","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cge.14078","article-title":"Kosaki overgrowth syndrome due to a novel de novo PDGFRB variant.","volume":"101","author":"Hern\u00e1ndez Dorronsoro","year":"2022","journal-title":"Clin Genet"},{"key":"R14-20260225","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrm1399","article-title":"Juxtamembrane autoinhibition in receptor tyrosine kinases.","volume":"5","author":"Hubbard","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R15-20260225","doi-asserted-by":"crossref","first-page":"38627","DOI":"10.1074\/jbc.M204890200","article-title":"Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor \u03b2 receptor.","volume":"277","author":"Irusta","year":"2002","journal-title":"J Biol Chem"},{"key":"R16-20260225","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1242\/jcs.191213","article-title":"Multiple routes of endocytic internalization of PDGFR\u03b2 contribute to PDGF-induced STAT3 signaling.","volume":"130","author":"Jastrz\u0119bski","year":"2017","journal-title":"J Cell Sci"},{"key":"R17-20260225","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1091\/mbc.e06-04-0306","article-title":"Loss of T-cell protein tyrosine phosphatase induces recycling of the platelet-derived growth factor (PDGF) \u03b2-receptor but not the PDGF \u03b1-receptor.","volume":"17","author":"Karlsson","year":"2006","journal-title":"Mol Biol Cell"},{"key":"R18-20260225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ajmg.c.31531","article-title":"Somatic overgrowth disorders of the PI3K\/AKT\/mTOR pathway & therapeutic strategies.","volume":"172","author":"Keppler\u2010Noreuil","year":"2016","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R19-20260225","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5581\/1516-8484.20110081","article-title":"Monitoring imatinib plasma concentrations in chronic myeloid leukemia.","volume":"33","author":"Martins","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"key":"R20-20260225","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/ajmg.a.38310","article-title":"Expansion of the phenotype of Kosaki overgrowth syndrome.","volume":"173","author":"Minatogawa","year":"2017","journal-title":"Am J Med Genet A"},{"key":"R21-20260225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000517978","article-title":"Kosaki overgrowth syndrome: report of a family with a novel PDGFRB variant.","volume":"13","author":"Mutlu Albayrak","year":"2021","journal-title":"Mol Syndromol"},{"key":"R23-20260225","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1074\/jbc.M115.705814","article-title":"The ubiquitin ligases c-Cbl and Cbl-b negatively regulate platelet-derived growth factor (PDGF) BB-induced chemotaxis by affecting PDGF receptor \u03b2 (PDGFR\u03b2) internalization and signaling.","volume":"291","author":"Rorsman","year":"2016","journal-title":"J Biol Chem"},{"key":"R24-20260225","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/ajmg.a.62264","article-title":"Positive response to imatinib in PDGFRB \u2010related Kosaki overgrowth syndrome.","volume":"185","author":"Rustad","year":"2021","journal-title":"Am J Med Genet A"},{"key":"R25-20260225","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jpeds.2014.10.015","article-title":"Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation.","volume":"166","author":"Takenouchi","year":"2015","journal-title":"J Pediatr"},{"key":"R26-20260225","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ajmg.c.31755","article-title":"Kosaki overgrowth syndrome: a newly identified entity caused by pathogenic variants in platelet\u2010derived growth factor receptor\u2010beta.","volume":"181","author":"Takenouchi","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R27-20260225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbrc.2023.04.099","article-title":"Activated EGFR and PDGFR internalize in separate vesicles and downstream AKT and ERK1\/2 signaling are differentially impacted by cholesterol depletion.","volume":"665","author":"W\u00e5hl\u00e9n","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"R28-20260225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpra.2020.07.001","article-title":"Carpal tunnel syndrome in paediatric patients: a novel association with Kosaki overgrowth syndrome.","volume":"25","author":"Walker","year":"2020","journal-title":"JPRAS Open"},{"key":"R29-20260225","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1074\/jbc.M311494200","article-title":"Platelet-derived growth factor receptor-mediated signal transduction from endosomes.","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"R30-20260225","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/ajmg.a.61615","article-title":"Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapy.","volume":"182","author":"Wenger","year":"2020","journal-title":"Am J Med Genet A"},{"key":"R31-20260225","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ajmg.a.61145","article-title":"Constitutive activation of the PI3K\u2010AKT pathway and cardiovascular abnormalities in an individual with Kosaki overgrowth syndrome.","volume":"179","author":"Zarate","year":"2019","journal-title":"Am J Med Genet A"}],"container-title":["Clinical Dysmorphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCD.0000000000000547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:00:29Z","timestamp":1772028029000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCD.0000000000000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mcd.0000000000000547","relation":{},"ISSN":["0962-8827","1473-5717"],"issn-type":[{"value":"0962-8827","type":"print"},{"value":"1473-5717","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2025-05-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}